SABCS 2022: T-DXd Yields Longer Overall Survival than T-DM1 in Patients with HER2+ MBC

Watch Now SABCS 2022: T-DXd Yields Longer Overall  Survival than T-DM1 in Patients with HER2+ MBC

SABCS 2022 - Racial Disparity in Pro-metastatic T-MEM Among Women With Residual BC After NAC

Watch Now SABCS 2022 - Racial Disparity in Pro-metastatic T-MEM Among Women With Residual BC After NAC

SABCS 2022 - Camizestrant May Be Superior to Fulvestrant in Patients With HR+/HER2- BC

Watch Now SABCS 2022 - Camizestrant May Be Superior to Fulvestrant in Patients With HR+/HER2- BC

SABCS 2022 : Genetic Profiling (POLAR) for Patients with BC may Safely Omit Radiation

Watch Now SABCS 2022 : Genetic Profiling (POLAR) for Patients with BC may Safely Omit Radiation

SABCS 2022 - Race and Clinical Outcomes in the RxPONDER Trial

Watch Now SABCS 2022 -  Race and Clinical Outcomes in the RxPONDER Trial